Search research articles
Contact Us
Filters
Showing results (111-120 of 434) with videos related to
Page
of 44
Sort By:
Bladder Cancer (Amsterdam, Netherlands)
|
December 19, 2018
Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?
Günter Niegisch, Christina Hulsbergen-van de Kaa, Martine Ploeg, et al.
World Journal of Urology
|
June 19, 2007
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
Antoine G van der Heijden, Christina A Hulsbergen-Van de Kaa, J Alfred Witjes
The Breast Journal
|
August 30, 2002
Ectopic breast cancer: special treatment considerations in the postmenopausal patient
Andrew K Roorda, James P Hansen, J Alfred Rider, et al.
Current Opinion in Urology
|
June 21, 2021
Patient-reported outcomes and health-related quality of life after urinary diversions
Siberyn T Nuijens, Hanny Cobussen-Boekhorst, John P F A Heesakkers, et al.
Urologic Oncology
|
March 15, 2011
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder
Seth P Lerner, Hao Liu, Meng-Fen Wu, et al.
The Journal of Urology
|
June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
Richard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology
|
August 27, 2013
Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection?
Ansje S Fortuin, Hanneke Meijer, Les C Thompson, et al.
World Journal of Urology
|
May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
Johannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Elife
|
October 15, 2024
Contrasting responses to aridity by different-sized decomposers cause similar decomposition rates across a precipitation gradient
Viraj R Torsekar, Nevo Sagi, J Alfred Daniel, et al.
European Urology
|
March 4, 2011
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer
Alessandro Sciarra, Jelle Barentsz, Anders Bjartell, et al.
Page
of 44
Search research articles
Search
Showing results (111-120 of 434) with videos related to
Sort By:
Page
of 44
Bladder Cancer (Amsterdam, Netherlands)
|
December 19, 2018
Do Orthotopic Ileal Diversions Induce Immunological Changes in Retained Urethral Tissue?
Günter Niegisch, Christina Hulsbergen-van de Kaa, Martine Ploeg, et al.
World Journal of Urology
|
June 19, 2007
The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis
Antoine G van der Heijden, Christina A Hulsbergen-Van de Kaa, J Alfred Witjes
The Breast Journal
|
August 30, 2002
Ectopic breast cancer: special treatment considerations in the postmenopausal patient
Andrew K Roorda, James P Hansen, J Alfred Rider, et al.
Current Opinion in Urology
|
June 21, 2021
Patient-reported outcomes and health-related quality of life after urinary diversions
Siberyn T Nuijens, Hanny Cobussen-Boekhorst, John P F A Heesakkers, et al.
Urologic Oncology
|
March 15, 2011
Fluorescence and white light cystoscopy for detection of carcinoma in situ of the urinary bladder
Seth P Lerner, Hao Liu, Meng-Fen Wu, et al.
The Journal of Urology
|
June 11, 2005
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials
Richard J Sylvester, Adrian P M van der Meijden, J Alfred Witjes, et al.
European Urology
|
August 27, 2013
Ferumoxtran-10 ultrasmall superparamagnetic iron oxide-enhanced diffusion-weighted imaging magnetic resonance imaging for detection of metastases in normal-sized lymph nodes in patients with bladder and prostate cancer: do we enter the era after extended pelvic lymph node dissection?
Ansje S Fortuin, Hanneke Meijer, Les C Thompson, et al.
World Journal of Urology
|
May 17, 2018
A placebo-controlled efficacy study of the intravesical immunomodulators TMX-101 and TMX-202 in an orthotopic bladder cancer rat model
Johannes Falke, Christina A Hulsbergen-van de Kaa, Roberto Maj, et al.
Elife
|
October 15, 2024
Contrasting responses to aridity by different-sized decomposers cause similar decomposition rates across a precipitation gradient
Viraj R Torsekar, Nevo Sagi, J Alfred Daniel, et al.
European Urology
|
March 4, 2011
Advances in magnetic resonance imaging: how they are changing the management of prostate cancer
Alessandro Sciarra, Jelle Barentsz, Anders Bjartell, et al.
Page
of 44